Belzutifan
Overview
Belzutifan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4585668).
API suppliers (3)
Suppliers of Belzutifan evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
2 of 3 hold a GMP certificate on record in the EU or UK registers
- APICORE US LLCUnited States1 active DMF
- VALARY LAB PRIVATE LIMITEDIndia1 active DMF GMP on record
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Belzutifan expires 30 Jun 2042 and exclusivity 12 Jun 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 3-[[(1S,2S,3R)-2,3-difluoro-1-hydroxy-7-methylsulfonyl-2,3-dihydro-1H-inden-4-yl]oxy]-5-fluorobenzonitrile
- Canonical SMILES
- CS(=O)(=O)C1=C2[C@@H]([C@@H]([C@@H](C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O
- InChIKey
- LOMMPXLFBTZENJ-ZACQAIPSSA-N
Do you supply Belzutifan? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.